Persistent Adrenocorticotropin Response to Desmopressin in the Early Postoperative Period Predicts Recurrence of Cushing's Disease

被引:39
作者
Losa, Marco [1 ]
Bianchi, Roberto [1 ]
Barzaghi, Raffaella [1 ]
Giovanelli, Massimo [1 ]
Mortini, Pietro [1 ]
机构
[1] Univ Vita Salute, Ist Sci San Raffaele, Dept Neurosurg, Pituitary Unit, I-20132 Milan, Italy
关键词
CORTICOTROPIN-RELEASING HORMONE; TRANSSPHENOIDAL SURGERY; PITUITARY SURGERY; STIMULATION TEST; DIFFERENTIAL-DIAGNOSIS; CORTISOL RESPONSE; SERUM CORTISOL; RISK; ACTH; REMISSION;
D O I
10.1210/jc.2009-0844
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Patients with Cushing's disease (CD) often show an ACTH and cortisol response to desmopressin (DDAVP). Objective: Wetested whether persistence of a positive response to DDAVP after successful surgery identifies patients at risk of CD recurrence. Design: We prospectively included all CD patients who had a positive response to DDAVP before successful surgery from 1995 through 2007. Setting: The study was performed at a university hospital. Patients: One hundred seventy-four patients with CD, 148 women and 26 men, mean age 36.1 +/- 0.8 yr, were studied. The median follow-up after surgery was 58 months (interquartile range 22-93 months). Intervention: DDAVP test was performed immediately before and after surgery. Main Outcome Measure: An ACTH and cortisol increment of at least 30 and 20% above baseline, respectively, were considered as a positive response to DDAVP. The risk of CD recurrence was analyzed according to the postoperative hormonal response to DDAVP. Results: Recurrence of CD occurred in 19 patients (10.9%). The recurrence-free survival at 5 yr was 89.8% [95% confidence interval (CI) 84.2-95.4]. Patients with a positive ACTH response had a 5-yr recurrence-free survival of 82.6% (95% CI 70.6-94.6%) as compared with 94.0% (95% CI 88.2-99.8%; P < 0.01) in patients without it. Multivariate analysis showed that persistence of a positive ACTH response to DDAVP was significantly associated with CD recurrence. Conclusion: Positive ACTH response to DDAVP after surgery is associated with an increased risk of CD recurrence. However, the specificity and predictive value of this finding are low. (J Clin Endocrinol Metab 94: 3322-3328, 2009)
引用
收藏
页码:3322 / 3328
页数:7
相关论文
共 29 条
[1]  
Ambrosi B, 2009, Clin Endocrinol (Oxf), V70, P811, DOI 10.1111/j.1365-2265.2008.03406.x
[2]   THE CORTICOTROPIN-RELEASING HORMONE TEST IN THE POSTOPERATIVE EVALUATION OF PATIENTS WITH CUSHINGS-SYNDROME [J].
AVGERINOS, PC ;
CHROUSOS, GP ;
NIEMAN, LK ;
OLDFIELD, EH ;
LORIAUX, DL ;
CUTLER, GB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (05) :906-913
[3]   FACTORS INFLUENCING THE IMMEDIATE AND LATE OUTCOME OF CUSHINGS-DISEASE TREATED BY TRANSSPHENOIDAL SURGERY - A RETROSPECTIVE STUDY BY THE EUROPEAN CUSHINGS-DISEASE SURVEY GROUP [J].
BOCHICCHIO, D ;
LOSA, M ;
BUCHFELDER, M ;
STEVENAERT, A ;
BECKERS, A ;
HAGEN, C ;
BJERRE, P ;
KRUSE, A ;
LINDHOLM, J ;
FAHLBUSCH, R ;
MULLER, OA ;
VONWERDER, K ;
AMBROSI, B ;
FAGLIA, G ;
GIOVANELLI, M ;
ANGELI, A ;
MAIRA, G ;
PIETERS, GFFM ;
CARVALHO, D ;
MEDINA, JL ;
COSTA, C ;
TELES, AG ;
GUERREIRO, L ;
RUAS, M ;
SALCEDO, I ;
DOLENC, V ;
JEZERNIK, M ;
VAZQUEZ, JA ;
GAZTAMBIDE, S ;
WEBB, SM ;
HALPERIN, I ;
VILARDELL, E ;
VIDAL, O ;
SANCHEZFRANCO, F ;
ASTORGA, R ;
LEALCERRO, A ;
LUNA, PPG ;
TORRES, E ;
THOREN, M ;
WERNER, S ;
LANDOLT, AM ;
ATKINSON, AB ;
MCCANCE, DR ;
GORDON, DS ;
HADDEN, DR ;
KENNEDY, L ;
SCANLON, MF ;
CRUICKSHANKS, G ;
TEASDALE, GM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (11) :3114-3120
[4]   Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome? [J].
Chee, GH ;
Mathias, DB ;
James, RA ;
Kendall-Taylor, P .
CLINICAL ENDOCRINOLOGY, 2001, 54 (05) :617-626
[5]   Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test [J].
Chen, JCT ;
Amar, AP ;
Choi, S ;
Singer, P ;
Couldwell, WT ;
Weiss, MH .
JOURNAL OF NEUROSURGERY, 2003, 98 (05) :967-973
[6]   Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess [J].
Colombo, P ;
Passini, E ;
Re, T ;
Faglia, G ;
Ambrosi, B .
CLINICAL ENDOCRINOLOGY, 1997, 46 (06) :661-668
[7]   Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing's disease [J].
Colombo, P ;
Dall'Asta, C ;
Barbetta, L ;
Re, T ;
Passini, E ;
Faglia, G ;
Ambrosi, B .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 143 (02) :227-234
[8]   Vasopressin receptor expression and mutation analysis in corticotropin-secreting tumors [J].
Dahia, PLM ;
AhmedShuaib, A ;
Jacobs, RA ;
Chew, SL ;
Honegger, J ;
Fahlbusch, R ;
Besser, GM ;
Grossman, AB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (05) :1768-1771
[9]   Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours [J].
de Keyzer, Y ;
René, P ;
Beldjord, C ;
Lenne, F ;
Bertagna, X .
CLINICAL ENDOCRINOLOGY, 1998, 49 (04) :475-482
[10]  
DELLASTA C, 2004, PITUITARY, V7, P183